US 12274684
Treatment of vasculopathy with prostacyclin and mesenchymal stem cells
granted A61KA61K31/557A61K31/5585
Quick answer
US patent 12274684 (Treatment of vasculopathy with prostacyclin and mesenchymal stem cells) held by United Therapeutics Corporation expires Mon Apr 10 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- United Therapeutics Corporation
- Grant date
- Tue Apr 15 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 10 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 14
- CPC classes
- A61K, A61K31/557, A61K31/5585, A61K35/28, A61P